FDA Inspection 860789 — SPI Pharma, Inc.
The FDA completed an inspection of SPI Pharma, Inc. on Nov 19, 2013 in Grand Haven, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 19, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Grand Haven, MI (United States)